Idiopathic cholesterol crystal embolism with atheroembolic renal disease and blue toes syndrome: A case report

doi:10.12998/wjcc.v10.i25.9162

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 10, Issue 25

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (3966)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-4) series, Tables (1-1) series.

Item

Count

PDF

141

WORD

HTML

1760

Figures (1-4)

377

Tables (1-1)

312

Sum=2648

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

363

Download

955

Sum=1318

Sep 6, 2022 (publication date) through Dec 26, 2024

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Clinical Cases

ISSN

2307-8960

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Case Report

World J Clin Cases. Sep 6, 2022; 10(25): 9162-9167
Published online Sep 6, 2022. doi: 10.12998/wjcc.v10.i25.9162

Full Size Figure Download Figure

Figure 4 Follow-up period over 12 mo. The reduced regimen of prednisone and the level of serum creatine and eosinophil count are shown. Scr: Serum creatine; ESO: Eosinophil count.

Citation: Cheng DJ, Li L, Zheng XY, Tang SF. Idiopathic cholesterol crystal embolism with atheroembolic renal disease and blue toes syndrome: A case report. World J Clin Cases 2022; 10(25): 9162-9167
URL: https://www.wjgnet.com/2307-8960/full/v10/i25/9162.htm
DOI: https://dx.doi.org/10.12998/wjcc.v10.i25.9162